Annika Teleman

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Ronald van Vollenhoven, Sofia Ernestam, P. Geborek et al. · The Lancet · 2009 · 316 citations

Inflammation, Rheumatology, Rheumatoid Disorder +12

Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)

Elke Theander, Tomas Husmark, Gerd-Marie Alenius et al. · Annals of the Rheumatic Diseases · 2013 · 172 citations

The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis

Mats Geijer, Ulla Lindqvist, Tomas Husmark et al. · The Journal of Rheumatology · 2015 · 80 citations · Full text

Remission and response to early treatment of RA assessed by the Disease Activity Score

Björn Svensson, C. Schaufelberger, Annika Teleman et al. · Lara D. Veeken · 2000 · 66 citations · Full text

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

Katerina Chatzidionysiou, Carl Turesson, Annika Teleman et al. · RMD Open · 2016 · 57 citations · Full text